Sugi Predict

Sugi Predict / Compounds / SCHEMBL12956409

SCHEMBL12956409

SCHEMBL12956409

CC(O)(c1ccccc1)[C@H]1CCCC2=Cc3c(cnn3-c3ccc(F)cc3)C[C@@]21C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 5/20 0.93
▸ GLUL P15104 3/20 0.93
▸ PGR P06401 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12956350 0.96 NR3C1 (1.00) NR3C1GLUL
SCHEMBL12956285 0.91 NR3C1 (0.89) NR3C1GLUL
SCHEMBL12956552 0.90 NR3C1 (0.79) NR3C1GLULPGR
SCHEMBL17066185 0.90 NR3C1 (1.00) NR3C1GLUL
SCHEMBL12956265 0.90 NR3C1 (1.00) NR3C1GLUL
SCHEMBL12956270 0.87 NR3C1 (0.79) NR3C1GLUL
SCHEMBL12956294 0.87 NR3C1 (0.82) NR3C1GLULPGR
SCHEMBL12956264 0.80 NR3C1 (0.69) NR3C1GLULPGR
SCHEMBL12956411 0.80 NR3C1 (0.67) NR3C1GLULPGR
SCHEMBL11995501 0.80 NR3C1 (1.00) NR3C1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1496892-B1 1H-BENZO(F)INDAZOL-5-YL DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS MERCK SHARP & DOHME (US) 2011-01-26 — — EP disclosed
US-7625937-B2 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators MERCK & CO., INC. (US) 2009-12-01 — — US disclosed
US-7625937-B2 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators MERCK & CO., INC. (US) 2009-12-01 — — US disclosed
US-20080097108-A1 Ophthalmic Compositions for Treating Ocular Hypertension MERCK SHARP & DOHME CORP. 2008-04-24 — — US disclosed
US-20080097108-A1 Ophthalmic Compositions for Treating Ocular Hypertension MERCK SHARP & DOHME CORP. 2008-04-24 — — US disclosed
US-20080076795-A1 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators MERCK SHARP & DOHME CORP. 2008-03-27 — — US disclosed
US-20080076795-A1 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators MERCK SHARP & DOHME CORP. 2008-03-27 — — US disclosed
US-7282591-B2 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators MERCK & CO., INC. (US) 2007-10-16 — — US disclosed
US-7282591-B2 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators MERCK & CO., INC. (US) 2007-10-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076795-A1 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators NR3C1, NR3C2, GRK5 NR3C1 1/4885GLUL 2420/4885PGR 135/4885
US-20080097108-A1 Ophthalmic Compositions for Treating Ocular Hypertension KCNH2, KCNN1, KCNH3 NR3C1 2494/4885GLUL 2702/4885PGR 3663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.